2022 Supported P&F Projects
|
Emily Hemann, PhD
|
Challenges and Opportunities of Adaptive Immunity in CF
|
|
Lauren Bakaletz, PhD
|
Testing a humanized monoclonal antibody directed at targeted protective domains of the bacterial DNABII proteins to disrupt nontuberculous mycobacteria (NTM) biofilms and render the newly released bacteria vulnerable to amikacin-mediated killing
|
2021 Supported P&F Projects
|
Murugesan Rajaram, PhD
|
Molecular mechanism of cardiac dysfunction during infection in CF
|
|
Erin Gloag, PhD
|
Biofilm Viscoelasticity as an Adaptive Survival Strategy in the CF Lung
|
2019 Supported P&F Projects
|
Prosper Boyaka, PhD
|
Adaptive Immunity in CF: Understanding B Cell Function
|
|
Richard Robinson, PhD
|
T Cell Dysfunction in CF Patients with Nontuberculous Mycobacteria
|
2018 Supported P&F Projects
|
Luanne Hall-Stoodley, PhD
|
The Role of Autophagy in Defective Mycobacterium Abscessus Clearance in CF Macrophages
|
|
Don Hayes Jr, MD
|
Epithelial Cell Chimerism in Cystic Fibrosis Lung Transplant Recipients
|
|
Mark Hester, PhD
|
Effects of CFTR Modulation on Mental Health and the NAA Pathway in Cystic Fibrosis
|
|
Houchon Harry Hu, PhD
|
Magnetic Resonance Elastography and 3D Printing in Cystic Fibrosis
|
|
Benjamin Kopp, MD, MPH
|
Role of CFTR and ENaC in Macrophage-Mediated Bacterial Killing
|
|
Maria Talavera, DO
|
The Role of DUSP6 in CF-Associated Intestinal Inflammation
|
|
Daniel Wozniak, PhDDirector, C3 P&F Program
Dr. Wozniak is a nationally recognized leader in CF training, serving as a standing member of the Cystic Fibrosis Foundation Research and Research Training Committee since 2008. He has trained 16 PhD students and 7 postdoctoral fellows, each having established independent careers in biomedical sciences.
|